if you remember (I've posted recently), my mom has received Ramucirumab or Placebo and a bit of Taxotere 10 days ago (Friday, 03.12.2012), I say "a bit", since she had an acute allergic reaction, so the infusion was stopped.
Last week we were waiting to hear about the half-life of Ramucirumab from the clinical trial sponsor, since the doctor was concerned to give my mom Alimta just like that. When yesterday they still did not call us, I phoned the doctor to ask. He again contacted the sponsor and received the answer that the half.life was three weeks and that we would need to wait another two weeks to start with Alimta!
Now, this has made me really upset and nervous. First, we do not know if my mom received Ramucirumab at all! The sponsor does not want to reveal it, since it would mess up their statistics (stats are more important then patients). Second, my mom has been diagnosed with these new mets to the liver ONE MONTH AGO already - and for one month she has been without therapy! If the mets were say 0.5cm, I would say perhaps - ok, what's another week or two. But they were 1.8cm! And God knows how big they are now. And I feel like we've been waiting too long anyhow. So I said that I do not understand what the concerns were. That Taxotere is anyhow given to Ramucirumab, and that my humble assumption is that they chose Taxotere since it's cheaper then Alimta. In addition, Alimta is given together with Avastin, which works in a similar (I know - not exact the same) way like Ramucirumab. But overall - her values are stable, blood is ok, blood pressure too - I don't want to wait another two weeks - and this perhaps in vain! Because, she might have as well received only a Placebo.
So the doctor said that for his own conscious he would wait these two weeks, but if we want to start next week, we can. And we said we want to - next Wednesday.
Was this a reasonable decision?!
Thanks a lot in advance!!!